Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...

The conversation isn’t going away for a few more weeks if you are the Minnesota Vikings. The discussion around the future of ...

Johnson & Johnson’s stock reversed gains made early Wednesday immediately after earnings were released, after the medical ...